Oral formulations have proven effective for both lowering blood glucose and weight loss
They did not repair anything
Both medications are highly effective for weight loss, but there are some key differences: Semaglutide (Ozempic/Wegovy): Primarily acts as a GLP-1 receptor agonist and has been shown to result in around 15-18% weight loss over time for many patients
Clinical trials of IGF-1 in multiple sclerosis (MS), ALS, Parkinsons disease (PD), and Alzheimers disease (AD) have yielded mixed results
Cell culture Baby hamster kidney (BHK) cells stably over-expressing human, cynomolgus, rat, mouse and pig GLP-1 receptor, human glucagon receptor, human GIP receptor, human GLP-2 receptor or co-expressing hGLP-1R and cAMP response element (CRE) coupled to firefly luciferase (CRE luciferase) were generated at Novo Nordisk A/S